Publication:
Effect of Hepatosteatosis on the Virological Response in Entecavir and Tenofovir Therapies

Loading...
Thumbnail Image

relationships.isOrgUnitOf

Program

relationships.isAuthorOf

Author

KORKMAZ, PINAR

Demirturk, Nese

Batirel, Ayse

Tulek, Necla

Ozguler, Muge

Harman, Rezan

Cinar, Gule

TOKA, ONUR

Yoruk, Gulsen

Ataman-Hatipoglu, Cigdem

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Objective: Both chronic hepatitis B (CHB) and hepatosteatosis may lead to necroinflammation in liver. Therefore, the presence of hepatosteatosis might negatively affect the efficacy of antiviral therapy. We aimed to determine the effect of hepatosteatosis on virological response in patients with CHB receiving entecavir (ETV) and tenofovir (TDF) treatment.

Description

Source

Keywords

Keywords

Citation

KORKMAZ P., Demirturk N., Batirel A., Tulek N., Ozguler M., Harman R., Cinar G., TOKA O., Yoruk G., Ataman-Hatipoglu C., et al., -Effect of Hepatosteatosis on the Virological Response in Entecavir and Tenofovir Therapies-, KLIMIK JOURNAL, cilt.32, ss.265-274, 2019

Endorsement

Review

Supplemented By

Referenced By

2

Views

0

Downloads

View PlumX Details


Sustainable Development Goals

Item type:Goal,